Jiangsu Hengrui Medicine (600276.SS) Cash on Hand
Market Cap: $314.93B
Avg Volume: 48.59M
Industry: Drug Manufacturers - General
Sector: Healthcare
How much cash does Jiangsu Hengrui Medicine have?
According to Jiangsu Hengrui Medicine 's latest annual financial reports, the company has a total of $24.82B in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.
Additionally, Jiangsu Hengrui Medicine holds $273.34M in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.
In total, the company has $25.09B when combining cash and cash equivalents with short-term investments.
On a per-share basis, Jiangsu Hengrui Medicine has $3.96 in cash. This metric helps investors understand how much cash the company holds per outstanding share.
The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $5.45B. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.
Lastly, the company's cash position has experienced a growth rate of 19.62%, reflecting the increase in cash and cash equivalents over the specified period.
Cash & Cash Equivalents
$24.82B
Short-Term Investments
$273.34M
Cash & Short-Term Investments
$25.09B
Cash Per Share
$3.96
Free Cash Flow
$5.45B
Cash Growth
19.62%
Jiangsu Hengrui Medicine Historical Cash on Hand
Cash on Hand History
The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2024.
| Year | Cash on Hand | Change |
|---|---|---|
| 2024 | $24.82B | 19.62% |
| 2023 | $20.75B | 37.29% |
| 2022 | $15.11B | 10.86% |
| 2021 | $13.63B | 26.16% |
| 2020 | $10.80B | 114.22% |
| 2019 | $5.04B | 29.67% |
| 2018 | $3.89B | -8.84% |
| 2017 | $4.27B | -13.13% |
| 2016 | $4.91B | -4.30% |
| 2015 | $5.13B | 48.83% |
| 2014 | $3.45B | 59.00% |
| 2013 | $2.17B | 63.16% |
| 2012 | $1.33B | 40.03% |
| 2011 | $949.39M | -4.59% |
| 2010 | $995.05M | 40.69% |
| 2009 | $707.25M | 83.61% |
| 2008 | $385.18M | -32.72% |
| 2007 | $572.49M | 1.23% |
| 2006 | $565.55M | 31.09% |
| 2005 | $431.43M | 18.70% |
| 2004 | $363.47M | 182.89% |
| 2003 | $128.48M | 8.07% |
| 2002 | $118.89M | -19.93% |
| 2001 | $148.48M | -58.74% |
| 2000 | $359.86M | 322.48% |
| 1999 | $85.18M | 246.67% |
| 1998 | $24.57M | 8.67% |
| 1997 | $22.61M | N/A |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.